Search Results 1-10 of 16260 for Aspergillosis
Aspergillosis is an infection caused by a type of mold (fungus). The illnesses resulting from aspergillosis infection usually affect the respiratory system ...
If the condition progresses, then antifungal medications may be recommended. Oral corticosteroids. The goal in treating allergic bronchopulmonary aspergillosis ...
This fungal lung infection is caused by inhaling certain mold spores. It may be serious in those with asthma or other chronic lung diseases.
Aspergillosis. Displaying 4 studies. A Registry of Antifungal Therapy in Adults with Either Invasive Mucormycosis or Invasive Aspergillosis Rochester, MN. The ...
... Aspergillosis (IPA). PC945 Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients Jacksonville, FL. The purpose of ...
Clinical Trials · PC945 Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients · More about research at Mayo Clinic.
For aspergillosis: Adults: · For blastomycosis or histoplasmosis: Adults: · For onychomycosis of the fingernails: Adults—200 milligrams (mg) 2 times a day for 1 ...
... aspergillosis (IA) caused by a non-fumigatus species. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...
Posaconazole delayed-release tablets is also used to treat invasive aspergillosis. Posaconazole oral suspension is also used to treat a fungus infection of the ...
Registry Study of Systemic Antifungal Therapy in Adult Subjects with Invasive Mucormycosis or Invasive Aspergillosis Caused by a Non-fumigatus Species · Share ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.